These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36980984)

  • 21. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p.
    Yang E; Xue L; Li Z; Yi T
    BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.
    Canzonieri V; D'Amore ES; Bartoloni G; Piazza M; Blandamura S; Carbone A
    Virchows Arch; 1994; 425(5):541-5. PubMed ID: 7850080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leiomyomas beyond the uterus; benign metastasizing leiomyomatosis with paraaortic metastasizing endometriosis and intravenous leiomyomatosis: a case series and review of the literature.
    Mahmoud MS; Desai K; Nezhat FR
    Arch Gynecol Obstet; 2015 Jan; 291(1):223-30. PubMed ID: 25047270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of miR-10a-5p and miR-103a-3p, Regulators of BDNF Expression in Follicular Fluid, in the Outcomes of IVF-ET.
    Zhang Q; Su J; Kong W; Fang Z; Li Y; Huang Z; Wen J; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():637384. PubMed ID: 34054723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravenous leiomyomatosis as a rare tumor of myometrium].
    Regász V; Boháč V; Rychnovský J
    Ceska Gynekol; 2018; 83(1):53-56. PubMed ID: 29510641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinicopathological and molecular analysis in uterine leiomyomas and concurrent/metachronous peritoneal nodules: New insights into disseminated peritoneal leiomyomatosis.
    Ma Y; Wang S; Liu Q; Lu B
    Pathol Res Pract; 2020 May; 216(5):152938. PubMed ID: 32234244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous leiomyomatosis of the uterus.
    Bodner K; Bodner-Adler B; Wierrani F; Mayerhofer K; Grünberger W
    Anticancer Res; 2002; 22(3):1881-3. PubMed ID: 12168887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.
    Sanz-Ortega J; Vocke C; Stratton P; Linehan WM; Merino MJ
    Am J Surg Pathol; 2013 Jan; 37(1):74-80. PubMed ID: 23211287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOV10 binding circ-DICER1 regulates the angiogenesis of glioma via miR-103a-3p/miR-382-5p mediated ZIC4 expression change.
    He Q; Zhao L; Liu X; Zheng J; Liu Y; Liu L; Ma J; Cai H; Li Z; Xue Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):9. PubMed ID: 30621721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing.
    Zhang X; Wu L; Xu R; Zhu C; Ma G; Zhang C; Liu X; Zhao H; Miao Q
    Sci Rep; 2019 Feb; 9(1):1442. PubMed ID: 30723247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 18 cases, with emphasis on early diagnosis and appropriate treatment strategies.
    Du J; Zhao X; Guo D; Li H; Sun B
    Hum Pathol; 2011 Sep; 42(9):1240-6. PubMed ID: 21777942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of intravenous leiomyomatosis with high levels of hyaluronan.
    Yaguchi C; Oi H; Kobayashi H; Miura K; Kanayama N
    J Obstet Gynaecol Res; 2010 Apr; 36(2):454-8. PubMed ID: 20492407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign pulmonary metastasizing leiomyomatosis: case report.
    Cobellis L; Castaldi MA; Mosca L; Frega V; Ambrosio D; Corvino F; Colacurci N
    Eur J Gynaecol Oncol; 2014; 35(2):195-8. PubMed ID: 24772929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
    Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
    Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting leiomyomas of the uterus other than cotyledonoid dissecting leiomyomas: a report of eight cases.
    Roth LM; Reed RJ
    Am J Surg Pathol; 1999 Sep; 23(9):1032-9. PubMed ID: 10478662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous leiomyomatosis.
    Diakomanolis E; Elsheikh A; Sotiropoulou M; Voulgaris Z; Vlachos G; Loutradis D; Michalas S
    Arch Gynecol Obstet; 2003 Feb; 267(4):256-7. PubMed ID: 12592433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case with diffuse uterine leiomyomatosis and review of the literature.
    Coskun A; Ozdemir O; Vardar MA; Kiran G; Arikan D; Ersoz C
    Clin Exp Obstet Gynecol; 2008; 35(3):227-30. PubMed ID: 18754301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.